These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1711 related items for PubMed ID: 81716

  • 1. Combination chemotherapy against B16 melanoma: bleomycin/vinblastine, bleomycin/cis-diamminedichloroplatinum, 5-fluorouracil/BCNU and 5-fluorouracil/methyl-CCNU.
    Mabel JA, Merker PC, Sturgeon ML, Wodinsky I, Geran RI.
    Cancer; 1978 Oct; 42(4):1711-9. PubMed ID: 81716
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC, Trader MW, Dykes DJ, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [Abstract] [Full Text] [Related]

  • 3. Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.
    Corbett TH, Griswold DP, Wolpert MK, Venditti JM, Schabel FM.
    Cancer Treat Rep; 1979 May; 63(5):799-801. PubMed ID: 455319
    [No Abstract] [Full Text] [Related]

  • 4. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
    Nathanson L, Wittenberg BK.
    Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
    [Abstract] [Full Text] [Related]

  • 5. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM.
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [Abstract] [Full Text] [Related]

  • 6. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E, Rovej R, Buzzoni R, Vaglini M, Bonadonna G.
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [Abstract] [Full Text] [Related]

  • 7. Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma.
    Nathanson L, Kaufman SD, Carey RW.
    Cancer; 1981 Sep 15; 48(6):1290-4. PubMed ID: 6168365
    [Abstract] [Full Text] [Related]

  • 8. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb 15; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET, Ahmann DL, Schutt AJ, Green SJ.
    Cancer Treat Rep; 1982 Mar 15; 66(3):567-9. PubMed ID: 6174231
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
    Liu X, Chan SY, Ho PC.
    Cancer Chemother Pharmacol; 2008 Dec 15; 63(1):167-74. PubMed ID: 18465132
    [Abstract] [Full Text] [Related]

  • 11. Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
    Jones AL, Millar JL, Millar BC, Powell B, Selby P, Winkley A, Lakhani S, Gore ME, McElwain TJ.
    Br J Cancer; 1990 Nov 15; 62(5):776-80. PubMed ID: 2245169
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Sequentially alternating chemotherapy of non-seminomatous testicular tumors with adriamycin/cisplatin and bleomycin/vinblastine. Therapeutic success and failure with respect to histology and tumor stages].
    Schütte J, Bremer K, Niederle N, Schoetensack B, Schmidt CG, Seeber S.
    Onkologie; 1983 Feb 15; 6(1):16-20. PubMed ID: 6189038
    [Abstract] [Full Text] [Related]

  • 14. Bleomycin in combination chemotherapy of metastatic Wilms tumor: a late recurrent case, refractory to conventional therapy.
    Kisielius T, Bianco A, Merrill JM, Taylor SG, DeWys W.
    Med Pediatr Oncol; 1979 Feb 15; 6(1):11-4. PubMed ID: 86941
    [Abstract] [Full Text] [Related]

  • 15. Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy.
    Entin I, Plotnikov A, Korenstein R, Keisari Y.
    Clin Cancer Res; 2003 Aug 01; 9(8):3190-7. PubMed ID: 12912972
    [Abstract] [Full Text] [Related]

  • 16. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA, Dougherty DV, Wilson CB, Rosenblum ML.
    J Neurosurg; 1983 Mar 01; 58(3):368-73. PubMed ID: 6827321
    [Abstract] [Full Text] [Related]

  • 17. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L, Zeuli M, Sega FM, Cognetti F.
    J Exp Clin Cancer Res; 2000 Mar 01; 19(1):21-34. PubMed ID: 10840932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G, Cenci E, Vecchiarelli A, Perito S.
    Boll Soc Ital Biol Sper; 1980 Oct 15; 56(19):1969-75. PubMed ID: 7459108
    [Abstract] [Full Text] [Related]

  • 20. The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice.
    Ballin A, Aladjem M, Banyash M, Boichis H, Barzilay Z, Gal R, Witz IP.
    Br J Cancer; 1983 Jul 15; 48(1):83-7. PubMed ID: 6191768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.